Dynamic Technology Lab’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Dynamic Technology Lab’s Portfolio JNCE Stock Details JNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,376	Closed	-$56K	–	1645
2022 Q2	$56K	Buy	+18,376	New	+$89.4K	0.01%	1024
2022 Q1	–	Sell	-17,913	Closed	-$150K	–	1649
2021 Q4	$150K	Buy	+17,913	New	+$148K	0.02%	1002
2021 Q2	–	Sell	-14,827	Closed	-$152K	–	1661
2021 Q1	$152K	Buy	+14,827	New	+$162K	0.02%	994
2018 Q4	–	Sell	-35,529	Closed	-$231K	–	1408
2018 Q3	$231K	Buy	+35,529	New	+$264K	0.03%	839
2018 Q2	–	Sell	-14,038	Closed	-$313K	–	1410
2018 Q1	$313K	Buy	+14,038	New	+$312K	0.05%	684

Other funds holding JNCE

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Dynamic Technology Lab's JNCE Position: Q3 2022 in Review

Dynamic Technology Lab sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q3 2022, closing a stake of 18,376 shares — an estimated $56K sold.

Dynamic Technology Lab first reported a position in JNCE in Q1 2018 and held it in 5 quarters. The position peaked at $313K in Q1 2018. 102 funds tracked by Wall St. Rank hold JNCE as of Q3 2022.

Dynamic Technology Lab reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Dynamic Technology Lab sold 18,376 Jounce Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $56K.
Dynamic Technology Lab first reported a position in Jounce Therapeutics, Inc. Common Stock in Q1 2018 and held it in 5 quarters.
Dynamic Technology Lab's Jounce Therapeutics, Inc. Common Stock position peaked at $313K in Q1 2018.
102 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Dynamic Technology Lab's 13F filing for Q3 2022, filed 14 Nov 2022.